Sentences with phrase «early breast cancer who»

Not exact matches

Or perhaps those folks too poor to afford insurance who will enjoy watching their mothers, wives and daughters die of breast cancer that could have been caught early by a government - subsidized mammogram.

For women who have a family history of breast cancer, mammogram screening usually begins 10 years earlier than family member's diagnosis

In any event, women who breastfeed cut their overall risk for early breast cancer (before menopause) in half.

Earlier studies have shown that mothers who nurse their babies exhibit lower risk of breast and ovarian cancers.

Now a University of Colorado Cancer Center study published online ahead of print in the journal Oncogene offers compelling evidence explaining this failure and offering a possible strategy for the use of retinoic acid or other retinoids against some breast cancers: Because early clinical trials are often offered to patients who have already tried other more established therapies, breast cancer cells may have been pushed past an important tipping point that offers retinoic acid resisCancer Center study published online ahead of print in the journal Oncogene offers compelling evidence explaining this failure and offering a possible strategy for the use of retinoic acid or other retinoids against some breast cancers: Because early clinical trials are often offered to patients who have already tried other more established therapies, breast cancer cells may have been pushed past an important tipping point that offers retinoic acid resiscancer cells may have been pushed past an important tipping point that offers retinoic acid resistance.

The researchers at 30 radiotherapy centres across the UK, led by The Institute of Cancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingcancer that was at a low risk of coming back.

«There is currently no method that can predict treatment outcome of chemotherapy early on in treatment, so this is a major advance,» says Hielscher, co-leader of the study, who is also a member of the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at NewYork - Presbyterian / Columbia University Irving Medical Center.

The findings reveal that breast cancer patients who received local anesthetic had superior pain relief, spent less time in recovery rooms after surgery, and were discharged an hour earlier than patients who were put under general anesthesia.

Prior studies that examined the impact of cancer treatment decisions on employment showed that patients who received chemotherapy were most likely to experience longer disruptions in or loss of employment, but changes in breast cancer management in recent years have shifted recommendations away from chemotherapy for early stage breast cancer.

Women who pursue a more aggressive surgery for early stage breast cancer have nearly eight times the odds of reporting substantial employment disruptions, according to a new study from University of Michigan Comprehensive Cancer Center researcancer have nearly eight times the odds of reporting substantial employment disruptions, according to a new study from University of Michigan Comprehensive Cancer Center researCancer Center researchers.

«These findings will give women with early stage breast cancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates CommCancer Research Advocates Committee.

The study, published in Cancer, surveyed 1,006 women who were treated for early stage breast cancer and were employed at the time of their diagCancer, surveyed 1,006 women who were treated for early stage breast cancer and were employed at the time of their diagcancer and were employed at the time of their diagnosis.

«Our findings highlight the potential value for a randomized controlled trial of aspirin as an agent in early detection of breast cancer, particularly for women with naturally dense tissues who may be at an increased risk for certain cancers,» said Despina Kontos, PhD, assistant professor of Radiology, and co-author on the study.

A study done by researchers at Fox Chase Cancer Center shows that many relatives of patients who undergo testing for a gene linked to breast and ovarian cancers misinterpret the results, and less than half of those who could benefit from genetic testing say they plan to get tested themselves — despite the fact that knowing your genetic status may help catch the disease in its earliest stages.

«If you are a young woman who was treated with radiation therapy to your chest as a teenager or child for HL, or for that matter chest radiation therapy for any reason, you should be having a conversation with your family doctor or your oncologist about whether to start breast cancer screening earlier than most women would,» says Dr. Hodgson.

Researchers at Princess Margaret Cancer Centre have confirmed in a screening effectiveness study that early screening with MRIs can reduce breast cancer mortality for female survivors of childhood Hodgkin's lymphoma (HL) who received chest radiCancer Centre have confirmed in a screening effectiveness study that early screening with MRIs can reduce breast cancer mortality for female survivors of childhood Hodgkin's lymphoma (HL) who received chest radicancer mortality for female survivors of childhood Hodgkin's lymphoma (HL) who received chest radiation.

Strikingly, the same signature was discovered in the blood of women without a BRCA1 mutation but who went on to develop breast cancer, making it a potential early marker of women's cancer in the general population.

«This readily suggests that estrogen could be given to MS patients, except that high levels of estrogen are linked to breast and uterine cancers,» said Tiwari - Woodruff, who joined UCR earlier this year.

We already know that tamoxifen can reduce the risk of cancer developing in some women who have early changes in the breast, but some get unacceptable side effects.

«This study demonstrates that Prosigna can reliably identify early stage breast cancer patients who have a low risk - of disease recurrence at 10 years, including a substantial proportion of patients with node - positive disease for whom the risk / benefit derived for adjuvant chemotherapy would be at best neutral,» said Dr. Alessandra Cesano, chief medical officer of NanoString Technologies.

Letrozole is approved by the FDA for the adjuvant treatment of early - stage breast cancer in postmenopausal women who have already been treated with 5 years of tamoxifen therapy.

Of the 1,551 women with early - stage breast cancer who were randomized to the comparison group of the WHEL study, more than half (864, or 56 percent) were taking tamoxifen, and more than three - quarters of those (674, or 78 percent) reported hot flashes.

Last month, a new study found that roughly 70 percent of women who carry cancer - predisposing mutations in the genes BRCA1 and BRCA2 (the main genes included in genetic tests for breast cancer patients) will develop breast cancer, often in early adulthood.

My translational research has focused on trying to find better ways to estimate recurrence risk in patients diagnosed with oestrogen - receptor positive early breast cancer, with the ultimate aim to better personalise our therapies for those patients who have the most to gain from them.

SEATTLE, Feb. 05, 2018 (GLOBE NEWSWIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a landmark study in which Danish researchers used the Prosigna ® Breast Cancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andBreast Cancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andCancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andcancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andbreast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andcancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 and 2003.

His sister, a lawyer who lived in Alabama, contracted breast cancer in the early 2000s but kept it to herself because their mother had dementia and she didn't want to upset her.

pSTAT5 is detected in human breast early lesions, especially in women who have had a pregnancy; therefore, prophylactic therapy targeting Jak2 - STAT5 signaling may lower breast cancer risk in high risk women.

The test signaled that Rancic, who has no family history of breast cancer, was in the early stages of the disease.

By Patrick Sauer TUESDAY, Dec. 16, 2008 (Health.com)-- Women who have been treated for early - stage breast cancer may have a lower risk of recurrence if they eat a relatively low - fat diet that's rich in fruits, vegetables, and fiber, according to a study published Monday in the Journal of Clinical Oncology.

People who exercise regularly have up to a 35 percent lower risk of coronary heart disease and stroke, up to a 50 percent lower risk of type 2 diabetes, up to a 50 percent lower risk of colon cancer, up to a 20 percent lower risk of breast cancer, a 30 percent lower risk of early death, to name a few.

In the late 80s and early 90s, the pink ribbon started appearing to commemorate those who had been affected by breast cancer and eventually organizations established this as the official symbol of breast cancer.

One study conducted by researchers at Women's Healthy Eating and Living (WHEL) followed women who had completed treatment for early stage breast cancer, and found that women with the highest blood concentrations of carotenoids had the least likelihood of cancer recurrence.

An earlier study in Finland found an increased risk of breast cancer among women who habitually used antibiotics to treat urinary tract infections.

According to researchers, girls who go through puberty early in life are at increased risk of developing breast and uterine cancer as well as suffer eating disorders, poor self - esteem, depression and increased likelihood of substance abuse.

Females who were spayed in early life also have a lower risk of breast cancer.

Zapharis has actually helped train dogs to detect early stage lung and breast cancers for two federally funded studies, as well as nine dogs who were trained to detect ovarian cancer.

They then collected data on the daughters, who are now in their late 40s and early 50s, to determine breast cancer rates.

The survival rate of women who detect breast cancer early is similarly high; more than 90 percent of women who detect and treat breast cancer in its early stages will survive.

More than 9 out of 10 women who detect breast cancer early live at least five years — and many live much longer.

Not only was Nancy, who was 32, young to have breast cancer, but like many who become ill at that early age, it was an extremely aggressive form.

She recalled a friend who was diagnosed with breast cancer and feared that if her diagnosis had come 20 years earlier, before the advancements made in breast cancer research, she would have been destined to die young.